Stephen A. Cochrane

1.7k total citations · 1 hit paper
40 papers, 1.3k citations indexed

About

Stephen A. Cochrane is a scholar working on Molecular Biology, Microbiology and Molecular Medicine. According to data from OpenAlex, Stephen A. Cochrane has authored 40 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Microbiology and 12 papers in Molecular Medicine. Recurrent topics in Stephen A. Cochrane's work include Antimicrobial Peptides and Activities (16 papers), Antibiotic Resistance in Bacteria (12 papers) and Microbial Natural Products and Biosynthesis (10 papers). Stephen A. Cochrane is often cited by papers focused on Antimicrobial Peptides and Activities (16 papers), Antibiotic Resistance in Bacteria (12 papers) and Microbial Natural Products and Biosynthesis (10 papers). Stephen A. Cochrane collaborates with scholars based in United Kingdom, Canada and Netherlands. Stephen A. Cochrane's co-authors include John C. Vederas, Christopher T. Lohans, Brandon Findlay, Pascal Mercier, Nathaniel I. Martin, Marco J. van Belkum, Wei Liu, Hongqiang Liu, Jeella Z. Acedo and Zedu Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Applied Physics Letters.

In The Last Decade

Stephen A. Cochrane

36 papers receiving 1.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lipopeptides from Bacillus and Paenibacillus spp.: A Gold Mine of Antibiotic Candidates

2014 381 citations Stephen A. Cochrane, John C. Vederas profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen A. Cochrane United Kingdom	18	723	390	320	230	218	40	1.3k
Anna Müller Germany	17	802 1.1×	409 1.0×	351 1.1×	134 0.6×	235 1.1×	25	1.3k
Nathan A. Magarvey Canada	14	886 1.2×	279 0.7×	486 1.5×	199 0.9×	96 0.4×	16	1.5k
Christopher T. Lohans Canada	26	880 1.2×	224 0.6×	399 1.2×	456 2.0×	430 2.0×	53	1.6k
Clarissa S. Sit Canada	19	1.1k 1.5×	308 0.8×	458 1.4×	466 2.0×	100 0.5×	26	1.7k
Amanda L. McClerren United States	16	787 1.1×	131 0.3×	237 0.7×	177 0.8×	284 1.3×	18	1.3k
Prerna N. Domadia Singapore	12	569 0.8×	481 1.2×	106 0.3×	143 0.6×	120 0.6×	15	1.0k
Linda Ejim Canada	17	627 0.9×	144 0.4×	295 0.9×	83 0.4×	470 2.2×	19	1.4k
Michaela Wenzel Germany	23	1.2k 1.7×	781 2.0×	214 0.7×	178 0.8×	293 1.3×	45	2.1k
Brandon Findlay Canada	17	516 0.7×	464 1.2×	192 0.6×	76 0.3×	288 1.3×	31	1.0k
Norris E. Allen United States	25	958 1.3×	281 0.7×	422 1.3×	187 0.8×	343 1.6×	38	1.9k

Countries citing papers authored by Stephen A. Cochrane

Since Specialization

Citations

This map shows the geographic impact of Stephen A. Cochrane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen A. Cochrane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen A. Cochrane more than expected).

Fields of papers citing papers by Stephen A. Cochrane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen A. Cochrane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen A. Cochrane. The network helps show where Stephen A. Cochrane may publish in the future.

Co-authorship network of co-authors of Stephen A. Cochrane

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen A. Cochrane. A scholar is included among the top collaborators of Stephen A. Cochrane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen A. Cochrane. Stephen A. Cochrane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Terlouw, Barbara R., Chao Du, Joost Willemse, et al.. (2024). Discovery and Derivatization of Tridecaptin Antibiotics with Altered Host Specificity and Enhanced Bioactivity. ACS Chemical Biology. 19(5). 1106–1115. 3 indexed citations

Willemse, Joost, et al.. (2024). A classic antibiotic reimagined: Rationally designed bacitracin variants exhibit potent activity against vancomycin-resistant pathogens. Proceedings of the National Academy of Sciences. 121(29). e2315310121–e2315310121. 11 indexed citations

Giltrap, Andrew M., Norman Morris, Yin Yao Dong, et al.. (2024). Lipid-Modulated, Graduated Inhibition of N-Glycosylation Pathway Priming Suggests Wide Tolerance of ER Proteostasis to Stress. ACS Central Science. 11(1). 107–115. 2 indexed citations

Oyama, Linda, Hamza Olleik, Fernanda Godoy-Santos, et al.. (2024). Microbiome-derived antimicrobial peptides show therapeutic activity against the critically important priority pathogen, Acinetobacter baumannii. npj Biofilms and Microbiomes. 10(1). 92–92. 7 indexed citations

Cochrane, Stephen A., et al.. (2024). A novel approach for the synthesis of the cyclic lipopeptide globomycin. RSC Medicinal Chemistry. 16(1). 373–378.

Martin, Nathaniel I., et al.. (2023). Linearization of the Brevicidine and Laterocidine Lipopeptides Yields Analogues That Retain Full Antibacterial Activity. Journal of Medicinal Chemistry. 66(8). 6002–6009. 13 indexed citations

Cochrane, Stephen A., et al.. (2023). Targeting membrane-bound bacterial cell wall precursors: a tried and true antibiotic strategy in nature and the clinic. Chemical Communications. 59(50). 7685–7703. 13 indexed citations

Zhong, Zheng, et al.. (2022). Synthetic studies with the brevicidine and laterocidine lipopeptide antibiotics including analogues with enhanced properties and in vivo efficacy. Chemical Science. 13(12). 3563–3570. 23 indexed citations

Cochrane, Stephen A., et al.. (2021). The tridecaptins: non-ribosomal peptides that selectively target Gram-negative bacteria. RSC Medicinal Chemistry. 12(4). 538–551. 21 indexed citations

10.

Calabrese, Camilla, Francisco J. Basterretxea, Stephen A. Cochrane, et al.. (2020). Observation of the Unbiased Conformers of Putative DNA-Scaffold Ribosugars. ACS Central Science. 6(2). 293–303. 15 indexed citations

11.

Caffrey, Martin, et al.. (2020). Undecaprenol kinase: Function, mechanism and substrate specificity of a potential antibiotic target. European Journal of Medicinal Chemistry. 210. 113062–113062. 8 indexed citations

12.

Cochrane, Stephen A. & Christopher T. Lohans. (2020). Breaking down the cell wall: Strategies for antibiotic discovery targeting bacterial transpeptidases. European Journal of Medicinal Chemistry. 194. 112262–112262. 40 indexed citations

13.

Tokajian, Sima, et al.. (2019). Tridecaptin-inspired antimicrobial peptides with activity against multidrug-resistant Gram-negative bacteria. MedChemComm. 10(3). 484–487. 16 indexed citations

14.

Li, Yong‐Xin, et al.. (2018). Rational design of new cyclic analogues of the antimicrobial lipopeptide tridecaptin A₁. Chemical Communications. 54(75). 10634–10637. 18 indexed citations

15.

Cochrane, Stephen A., et al.. (2016). Antimicrobial lipopeptide tridecaptin A ₁ selectively binds to Gram-negative lipid II. Proceedings of the National Academy of Sciences. 113(41). 11561–11566. 110 indexed citations

16.

Cochrane, Stephen A., Brandon Findlay, John C. Vederas, & Elaref Ratemi. (2014). Key Residues in Octyl‐Tridecaptin A₁ Analogues Linked to Stable Secondary Structures in the Membrane. ChemBioChem. 15(9). 1295–1299. 28 indexed citations

17.

Kwon, Moonhyuk, Stephen A. Cochrane, John C. Vederas, & Dae‐Kyun Ro. (2014). Molecular cloning and characterization of drimenol synthase from valerian plant (Valeriana officinalis). FEBS Letters. 588(24). 4597–4603. 25 indexed citations

18.

Cochrane, Stephen A., Zedu Huang, & John C. Vederas. (2012). Investigation of the ring-closing metathesis of peptides in water. Organic & Biomolecular Chemistry. 11(4). 630–639. 16 indexed citations

19.

Singh, Prashant, Stephen A. Cochrane, D. B. Knorr, et al.. (1995). High-frequency response of capacitors fabricated from fine grain BaTiO3 thin films. Applied Physics Letters. 66(26). 3683–3685. 13 indexed citations

20.

Cochrane, Stephen A., et al.. (1993). Deposition, Structural Characterization, and Broadband (1KHz-40GHz) Dielectric Behavior of Ba_xTi_2-xO_y Thin Films. MRS Proceedings. 310. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact